SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NSIX -- Neuromedical Systems, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry Fahy who wrote (7)9/21/1997 10:56:00 PM
From: David and Elena Krikorian   of 137
 
Dan and Larry,

I spoke with a gentleman who is very close to the company this past Friday. A couple of pieces of info I can share with you is that there was a small group of shorts who drove this stock down to the $3 level. What happens now is anyone's guess. NSIX short interest stood at 1.46 million shares as of 8/15/97. It is probably somewhat lower given the recent volume and price movements.

I will be speaking to an official at the company this week to try and understand what the next steps are. I have been told that between NSIX and it's competitors Neopath, cytex et al., NSIX has the hands down best screeening process on the market. This stock should be priced significantly higher than it's current level. Revenues should show a strong increase this quarter and we may start to see some coverage intitiated. I was told that Smith Barney and Merrill were responsable for the big volume two weeks ago by issuing buy reccomendations to thier institutional clients. I have reason to beleive this to be correct because the volume had nothing to do with the press release on helping indigent women.

I have also been told that PAPNET is "standard of care" for one large insurance group and that doctors must have patient sign-off to not perform the PAPNET test.

Lastly, the PAPNET system is designd to recognize somthing like 124 attributes on a smear which cannot be detected by the human technician.

I am hoping that NSIX will see 7 by mid november and if I'm really lucky 9-10. Even at 10 it is way underpriced verses it's peer group.

PS - check out a company called Q-med (QEKG small-cap) I have been following this stock for over two years. Get in for a nice ride over the next month.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News